Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (2020) | AcademicGPT, tlooto

Remdesivir (RDV) has superior anti-MERS activity in vitro and in vivo compared to combination therapy with lopinavir, ritonavir and interferon beta and reduces severe lung pathology. (2020), Nature Communications, Sheahan T. | AcademicGPT, tlooto for Academic and Research